For ischemic brain damage, is preclinical evidence of neuroprotection by presynaptic blockade of glutamate release enough?
- 31 January 2000
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 54 (1) , 77-79
- https://doi.org/10.1054/mehy.1998.0831
Abstract
No abstract availableKeywords
Funding Information
- Instituto Mexicano del Seguro Social
- Universidad Autónoma del Estado de Morelos
This publication has 11 references indexed in Scilit:
- Pharmacological Treatment of Central Nervous System TraumaBasic & Clinical Pharmacology & Toxicology, 1996
- Meta-analysis: A method for synthesizing research*Clinical Pharmacology & Therapeutics, 1995
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injuryBrain Research, 1995
- Prophylactic neuroprotection for cerebral ischemia.Stroke, 1994
- Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodentsNeuroscience Letters, 1994
- The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological studyNeuroscience, 1993
- BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.Stroke, 1993
- Limiting Ischemic Injury by Inhibition of Excitatory Amino Acid ReleaseJournal of Cerebral Blood Flow & Metabolism, 1993
- Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemiaNeuroscience Letters, 1992